These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6839959)

  • 1. Familial warfarin resistance.
    Holt RJ; Freytes CO
    Drug Intell Clin Pharm; 1983 Apr; 17(4):281-3. PubMed ID: 6839959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warfarin resistance: diagnosis and therapeutic alternatives.
    Hulse ML
    Pharmacotherapy; 1996; 16(6):1009-17. PubMed ID: 8947972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin resistance associated with parenteral nutrition.
    Cheung LK; Agi R; Hyman DJ
    Am J Med Sci; 2012 Mar; 343(3):255-8. PubMed ID: 22143126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coumarin anticoagulant drugs: hereditary resistance in man.
    O'Reilly RA; Aggeler PM
    Fed Proc; 1965; 24(6):1266-73. PubMed ID: 5853147
    [No Abstract]   [Full Text] [Related]  

  • 5. Early mechanical mitral valve thrombosis in a patient with warfarin resistance.
    Yasar AS; Balbay Y; Maden O; Sasmaz H
    J Heart Valve Dis; 2007 Mar; 16(2):200-2. PubMed ID: 17484471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale, design, and protocol of a randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous thrombosis.
    Ferro JM; Dentali F; Coutinho JM; Kobayashi A; Caria J; Desch M; Fraessdorf M; Huisman H; Diener HC
    Int J Stroke; 2018 Oct; 13(7):766-770. PubMed ID: 29775170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin resistance.
    Sinxadi P; Blockman M
    Cardiovasc J Afr; 2008; 19(4):215-7. PubMed ID: 18776969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fondaparinux as alternative anticoagulant to warfarin or low-molecular-weight heparin for recurrent venous thrombosis.
    Thachil J
    Ann Pharmacother; 2014 Mar; 48(3):420-4. PubMed ID: 24473488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.
    Palareti G; Legnani C
    Clin Pharmacokinet; 1996 Apr; 30(4):300-13. PubMed ID: 8983860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin dose related to apolipoprotein E (APOE) genotype.
    Kohnke H; Sörlin K; Granath G; Wadelius M
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):381-8. PubMed ID: 15952022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin resistance in a patient with short bowel syndrome.
    Brophy DF; Ford SL; Crouch MA
    Pharmacotherapy; 1998; 18(3):646-9. PubMed ID: 9620117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver.
    Hildebrandt EF; Suttie JW
    Biochemistry; 1982 May; 21(10):2406-11. PubMed ID: 6807339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible failure of novel direct-acting oral anticoagulants in management of pulmonary embolism: a case report.
    Rankin J; Nagar M; Crosby J; Toomari N; Pietras R; Ben-Zur UM
    J Med Case Rep; 2016 Dec; 10(1):346. PubMed ID: 27912791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hereditary warfarin resistance].
    Lappegård KT
    Tidsskr Nor Laegeforen; 2000 Nov; 120(27):3257-8. PubMed ID: 11187165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exacerbation of hereditary warfarin resistance by azathioprine.
    Pushpakom SP; Gambhir N; Latif A; Hadfield KD; Campbell S; Newman WG
    Clin Appl Thromb Hemost; 2011 Jun; 17(3):293-6. PubMed ID: 20211925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2.
    Rost S; Fregin A; Ivaskevicius V; Conzelmann E; Hörtnagel K; Pelz HJ; Lappegard K; Seifried E; Scharrer I; Tuddenham EG; Müller CR; Strom TM; Oldenburg J
    Nature; 2004 Feb; 427(6974):537-41. PubMed ID: 14765194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
    Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of the Rate of Gastrointestinal Bleeding in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin.
    Cangemi DJ; Krill T; Weideman R; Cipher DJ; Spechler SJ; Feagins LA
    Am J Gastroenterol; 2017 May; 112(5):734-739. PubMed ID: 28244496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent warfarin-induced skin necrosis in kindreds with protein S deficiency.
    Sallah S; Abdallah JM; Gagnon GA
    Haemostasis; 1998; 28(1):25-30. PubMed ID: 9885367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pesticide resistance in wild mammals--mechanisms of anticoagulant resistance in wild rodents.
    Ishizuka M; Tanikawa T; Tanaka KD; Heewon M; Okajima F; Sakamoto KQ; Fujita S
    J Toxicol Sci; 2008 Aug; 33(3):283-91. PubMed ID: 18670159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.